Celyad Oncology and Cryoport Systems present the results of their collaboration at the International Society for Cell & Gene Therapy (ISCT) 2025.
Elevator Pitch Session: Wednesday May 7, 2025 12:00PM – 1:00PM by Alexandre Michaux, Cryoport Systems
Poster Presentation: Cryo-processed leukapheresis demonstrates as high quality starting material to support autologous and allogeneic CAR-T cell therapy manufacturing – Poster #831 – Thursday May 8, 2025 6:00PM – 7:30PM

Our team will be presenting at the Advanced Therapies week in Dallas! Meet us at the Autologous Cell Therapies session on Wed 22nd!

Our team will be attending the 5th International Conference on Lymphocyte Engineering (ICLE) in Munich!
Please come to see us at Poster board 25 to see our poster during the Welcome Reception on 20 February, from 18:15 to 20:00, in the designated Poster Zone.

Our team will be presenting at the 2nd Annual Immuno-Bio Series organized by Markets and Markets.

Our team will present two posters at the 39th Annual SITC meeting – come to see them and discuss our latest advances!!

• Abstract 262: PSMA/NKG2DL tandem CAR T-cells to overcome antigen heterogeneity and improve anti-tumor efficacy against prostate cancer. To be presented on Saturday, November 9 at the Poster session (Cellular Therapies)
• Abstract 1133: Efficient, safe and customizable modulation of multiple target genes in CAR T-cells through a miRNA-based shRNA platform. To be presented on Friday November 8 at the Poster session (Immuno-Engineering)

We shall present at the Advanced Therapies Europe at the Autologous Cell Therapy: Advancements, Challenges, and Future Directions session on Sep 11 and at the Allogeneic Cell Therapies: Spotlight on Innovations and Potential session on Sep 12